» Articles » PMID: 30779660

Imaging Characteristics of Liver Metastases Overlooked at Contrast-Enhanced CT

Overview
Specialties Oncology
Radiology
Date 2019 Feb 20
PMID 30779660
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study was to evaluate the imaging characteristics of liver metastases overlooked at contrast-enhanced CT.

Materials And Methods: The records of 746 patients with a diagnosis of liver metastases from colorectal, breast, gastric, or lung cancer between November 2010 and September 2017 were reviewed. Images were reviewed when liver metastases were first diagnosed, and images from prior contrast-enhanced CT examinations were checked if available. These lesions were classified into two groups: missed lesions (those missed on the prior images) and detected lesions (those correctly identified and invisible on the prior images or there were no prior images). Tumor size, contrast-to-noise ratio, location, presence of coexisting liver cysts and hepatic steatosis, and indications for examination were compared between the groups. The t test and Fisher exact test were used to analyze the imaging characteristics of previously overlooked lesions.

Results: The final analysis included 137 lesions, of which 68 were classified as missed. In univariate analysis, contrast-to-noise ratio was significantly lower in missed lesions (95% CI, 2.65 ± 0.24 vs 3.90 ± 0.23; p < 0.001). The proportion of subcapsular lesions (odds ratio, 3.44; p < 0.001), hepatic steatosis (odds ratio, 6.35; p = 0.007), and examination indication other than survey of malignant tumors (odds ratio, 9.07; p = 0.02) were significantly higher for missed lesions.

Conclusion: Liver metastases without sufficient contrast enhancement, those in patients with hepatic steatosis, those in subcapsular locations, and those found at examinations for indications other than to assess for tumors were significantly more likely to be overlooked.

Citing Articles

Assessing the Significance and Progression of Too Small to Characterize Lesions in Hepatic CT Scans of Patients With a Cancer History: A Two-Center Cross-Sectional Study.

Khoroushi F, Moeini M, Jarahi L, Hassannejad E, Kharghani F, Moodi Ghalibaf A Health Sci Rep. 2025; 8(3):e70374.

PMID: 40041777 PMC: 11872801. DOI: 10.1002/hsr2.70374.


Peripheral liver metastases are more frequently missed than central metastases in contrast-enhanced CT: insights from a 25-reader performance study.

Hsieh S, Holmes Iii D, Carter R, Tan N, Inoue A, Yalon M Abdom Radiol (NY). 2024; 50(2):668-676.

PMID: 39162799 PMC: 11794030. DOI: 10.1007/s00261-024-04520-4.


Preoperative imaging of colorectal liver metastases: what the radiologist and the multidisciplinary team need to know.

Dempsey P, Farrelly C, Cronin C, Fenlon H Br J Radiol. 2024; 97(1162):1602-1618.

PMID: 39078288 PMC: 11417391. DOI: 10.1093/bjr/tqae133.


Benign and malignant focal liver lesions displaying rim arterial phase hyperenhancement on CT and MRI.

Matteini F, Cannella R, Garzelli L, Dioguardi Burgio M, Sartoris R, Brancatelli G Insights Imaging. 2024; 15(1):178.

PMID: 39020233 PMC: 11254889. DOI: 10.1186/s13244-024-01756-y.


Distinct CT imaging features of new liver metastases from primary genitourinary cancers.

Kim T, Law W, Kalaycioglu B, Gangai N, Do R Abdom Radiol (NY). 2024; 49(7):2209-2219.

PMID: 38769200 PMC: 11687366. DOI: 10.1007/s00261-024-04296-7.